Protein kinase C β inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats

Journal of Pharmacological Sciences

Volumn 101, Issue 4, 2006, Pages 335-343

  Wu, Yonggui ^a   Wu, Guozhong ^a   Qi, Xiangming ^a   Lin, Hui ^a   Qian, Hao ^a   Shen, Jijia ^a   Lin, Shantan ^b  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Intercellular adhesion molecule 1; LY333531; Macrophage; Monocyte chemotactic protein 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA INHIBITOR; RUBOXISTAURIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; IN VITRO STUDY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; STREPTOZOCIN DIABETES;

EID: 33747855849     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0050896     Document Type: Article

References (43)

1. Coimbra TM, Janssen U, Grone HJ, Ostendorf T, Kunter U, Schmidt H, et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int. 2000;57:167-182.
2. Phillips AO, Baboolal K, Riley S, Grone H, Janssen U, Steadman R, et al. Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin dependent diabetes mellitus. Am J Kidney Dis. 2001;37:400-410.
3. Sassy-Prigent C, Heudes D, Mandet C, Belair MF, Michel O, Perdereau B, et al. Early glomerular macrophage recruitment in streptozotocin- induced diabetic rats. Diabetes. 2000;49:466-475.
4. Chow F, Ozols E, Nikolic-Paterson DJ, Atkins RC, Tesch GH. Macrophages in mouse type 2 diabetic nephropathy: correlation with diabetic state and progressive renal injury. Kidney Int. 2004;65:116-128.
5. Nathan CF. Secretory products of macrophages. J Clin Invest. 1987;79:319-326.
6. Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophages produces reactive oxygen species in experimental glomerulonephritis. Kidney Int. 1989;35:778-782.
7. Lovett DH, Ryan JL, Steizel RB. Stimulation of rat mesangial cell proliferation by macrophage interleukin-1. J Immunol. 1983;131:2830-2836.
8. Schreiner GF, Kohan DE. Regulation of renal transport processes and hemodynamics by macrophages and lymphocytes. Am J Physiol. 1990;258:F761-F767.
9. Oberle GP, Niemeyer J, Thaiss F, Schoeppe W, Stahl RA. Increased oxygen radical and eicosanoid formation in immune-mediated mesangial cell injury. Kidney Int. 1992;42:69-74.
10. Craven PA, DeRubertis FR. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest. 1989;83:1667-1675.
11. Ishii H, Jirousek MR, Koya D, Takaji C, Xia P, Clermont A, et al. Amelioration of vascular dysfunction in diabetic rats by an oral PKC β inhibitor. Science. 1996;272:728-731.
12. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db /db mice, a rodent model for type 2 diabetes. FASEB J. 2000;14:439-447.
13. Kelly DJ, Zhang Y, Hepper C, Gow RM, Jaworski K, Kemp BE, et al. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes. 2003;52:512-518.
14. Kelly DJ, Chanty A, Gow RM, Zhang Y, Gilbert RE. Protein kinase C beta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy. J Am Soc Nephrol. 2005;16:1654-1660.
15. Park CW, Kim JH, Lee JH, Kim YS, Ahn HJ, Shin YS, et al. High glucose-induced intercellular adhesion molecule-1 (ICAM-1) expression through an osmotic effect in rat mesangial cells is PKC-NF-kappa B-dependent. Diabetologia. 2000;43:1544-1553.
16. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int. 2000;58:684-690
17. Anderson S, Rennke HG, Brenner BM. Nifedipine versus fosinopril in uninephrectomized diabetic rats. Kidney Int. 1992;41:891-897.
18. Weibel ER. Stereological methods: practical methods for biological morphometry. London: Academic Press; 1979. p. 162-203.
19. Cao Z, Cooper ME, Wu LL, Cox AJ, Jandeleit-Dahm K, Kelly DJ, et al. Blockade of the rennin angiotensin and endothelin systems on progressive renal injury. Hypertension. 2000;36:561-568.
20. Bradford MM. A rapid and sensitive method of the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem. 1976;72:248-254.
21. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y. Translocation of protein kinase C alpha and zeta in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia. 1994;37:838-841.
22. Heasley LE, Johnson GL. Regulation of protein kinase C by nerve growth factor, epidermal growth factor, and phorbol esters in PC12 pheochromocytoma cells. J Biol Chem. 1989;264:8646-8652.
23. Mai M, Geiger H, Hilgers KF, Veelken R, Mann JF, Dammrich J. Early interstitial changes in hypertension-induced renal injury. Hypertension. 1993;22:754-765.
24. Bonnet F, Cooper M, Kawachi H, Allen TJ, Boner G, Cao Z. Irbesartan normalizes the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia. 2001;44:874-877.
25. Aoyama I, Shimokata K, Niwa T. An oral adsorbent downregulates renal expression of genes that promote interstitial inflammation and fibrosis in diabetic rats. Nephron. 2002;92:635-651.
26. Rothlein R, Wegner C. Role of intercellular adhesion molecule-1 in the inflammatory response. Kidney Int. 1992;41:617-627.
27. Eddy AA, Giachelli CM. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int. 1995;47:1546-1557.
28. Chow J, Hartley RB, Jagger C, Dilly SA. ICAM-1 expression in renal disease. J Clin Pathol. 1992;45:880-884.
29. Hirata K, Shikata K, Matsuda M, Akiyama K, Sugimoto H, Kushiro M, et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia. 1998;41:185-192.
30. Sugimoto H, Shikata K, Hirata K, Akiyama K, Matsuda M, Kushiro M, et al. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes. 1997;46:2075-2081.
31. Okada S, Shikata K, Matsuda M, Ogawa D, Usui H, Kido Y, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes. Diabetes. 2003;52:2586-2593.
32. Luster AD. Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med. 1998;338:436-445.
33. Banba N, Nakamura T, Matsumura M, Kuroda H, Hattori Y, Kasai K. Possible relationship of monocyte chemoattractant protein-1 with diabetic nephropathy. Kidney Int. 2000;58:684-690.
34. Wada T, Furuichi K, Sakai N, Iwata Y, Yoshimoto K, Shimizu M, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesion of human diabetic nephropathy. Kidney Int. 2000;58:1492-1499.
35. Rovin BH, Tanl C. LDL stimulates mesangial fibronectin and chemoattactant expression. Kidney Int. 1993;43:218-225.
36. Ihm CG, Park JK, Hong SP, Lee TW, Cho BS, Kim MJ, et al. A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells. Nephron. 1998;79:33-37.
37. Schena FP, Gesualdo L, Grandaliano G, Montinaro V. Progression of renal damage in human glomerulonephritides: Is there sleight of hand in winning the game? Kidney Int. 1997;52:1439-1457.
38. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB. Role of high glucose-induced nuclear factor-κB activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol. 2002;13:894-902.
39. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, et al. NF-κB and Sp1 regulates transcription of the human monocyte chemoattractant protein-1 gene. J Immunol. 1994;153:2052-2063.
40. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47:859-866.
41. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, et al. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939-1945.
42. Studer RK, Craven PA, DeRubertix FR. Antioxidant inhibition of protein kinase C-signaled increase in transforming growth factor-beta in mesangial cells. Meatbolism. 1997;46:918-925.
43. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-790.